共 107 条
[11]
Bjerre LM(2000)The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data Br J Cancer 83 1556-1558
[12]
LeLorier J(2002)3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis Gastroenterology 122 308-317
[13]
Blais L(1998)Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis Int J Oncol 12 717-723
[14]
Desgagné A(1996)Carcinogenicity of lipid-lowering drugs JAMA 275 55-60
[15]
LeLorier J(2002)3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA Circ Res 91 143-150
[16]
Coogan PF(2002)Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project Circulation 105 2341-2346
[17]
Rosenberg L(1996)The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1001-1009
[18]
Palmer JR(2002)Statins have biphasic effects on angiogenesis Circulation 105 739-745
[19]
Strom BL(2002)HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 508-519
[20]
Zauber AG(undefined)undefined undefined undefined undefined-undefined